 |
|
LETTER TO THE EDITOR |
|
| Year : 2015 | Volume
: 10
| Issue : 3 | Page : 217-218 |
|
| Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives |
|
|
Filippo Lococo1, Alessandro Stefani2, Giorgio Treglia3
1 Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
2 Unit of Thoracic Surgery, University of Modena, Modena, Italy
3 Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, Europe, Switzerland
| Date of Web Publication | 15-Jul-2015 |
Correspondence Address:
Filippo Lococo
Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia
Italy
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.157292
|
|
How to cite this article:
Lococo F, Stefani A, Treglia G. Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives. Ann Thorac Med 2015;10:217-8 |
How to cite this URL:
Lococo F, Stefani A, Treglia G. Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives. Ann Thorac Med [serial online] 2015 [cited 2023 Apr 1];10:217-8. Available from: https://www.thoracicmedicine.org/text.asp?2015/10/3/217/157292 |
.
|
|
| This article has been cited by | | 1 |
Current Applications for Nuclear Medicine Imaging in Pulmonary Disease |
|
| Joanna E. Kusmirek, Josiah D. Magnusson, Scott B. Perlman | | Current Pulmonology Reports. 2020; 9(3): 82 | | [Pubmed] | [DOI] | |
|
|
 |
|
|
|
